crovalimab
Showing 1 - 6 of 6
Guillain-Barré Syndrome Trial (Crovalimab, Placebo, Intravenous immunoglobulin therapy)
Not yet recruiting
- Guillain-Barré Syndrome
- Crovalimab
- +2 more
- (no location specified)
Aug 8, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in China (Crovalimab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Crovalimab
-
Changchun City, China
- +5 more
Jul 11, 2022
Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (Crovalimab, Placebo)
Active, not recruiting
- Paroxysmal Hemoglobinuria, Nocturnal
- Crovalimab
- Placebo
-
Paris, France
- +18 more
Dec 5, 2022
Sickle Cell Disease Trial in Italy, Spain, United States (Crovalimab, Placebo)
Recruiting
- Sickle Cell Disease
- Crovalimab
- Placebo
-
New York, New York
- +18 more
Jan 4, 2023
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Crovalimab)
Recruiting
- Atypical Hemolytic Uremic Syndrome
- Crovalimab
-
Hollywood, Florida
- +25 more
Aug 23, 2022
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Crovalimab)
Recruiting
- Atypical Hemolytic Uremic Syndrome
- Crovalimab
-
Orange, California
- +63 more
Jan 9, 2023